Financials

  • Market Capitalization 730.2 M
  • Employee 121
  • Founded 2013
  • CEO N/A
  • Website www.solidbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00JN4FXG8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.83
Rapporto prezzo/fatturato
530.1

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2582
ACHV
Achieve Life Sciences, Inc. - Common Shares
7.13 USD-3.78%+2.15%+0.99%+128.53%733.69 M USD
2596
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
13.19 USD-1.05%+1.77%-3.30%+16.73%728.67 M USD
2603
DSGN
Design Therapeutics, Inc. - Common Stock
11.52 USD-1.12%-5.34%-21.69%+70.67%720.94 M USD
2604
LXRX
Lexicon Pharmaceuticals, Inc. - Common Stock
1.63 USD-2.98%-7.39%-17.68%+7.95%725.28 M USD

Notizie